510(k) DEN140004
DEN140004 is an FDA 510(k) premarket notification submitted by Diagnostic Hybrids, Inc. for the device "QUIDEL MOLECULAR DIRECT HSV 1 +2/VZV ASSAY". The FDA issued a decision of De Novo Granted on May 13, 2014. The device falls under product code PGI (Herpes Virus (Vzv, Hsv1, Hsv2), Dna Detection Assay For Cutaneous And Mucocutaneous Lesion Samples), a Class II device regulated under 21 CFR 866.3309. Diagnostic Hybrids, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- DENG (De Novo Granted)
- Decision Date
- May 13, 2014
- Date Received
- February 21, 2014
- Clearance Type
- Post-NSE
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Herpes Virus (Vzv, Hsv1, Hsv2), Dna Detection Assay For Cutaneous And Mucocutaneous Lesion Samples
- Device Class
- Class II
- Regulation Number
- 866.3309
- Review Panel
- MI
- Submission Type
For the qualitative detection and differentiation of VZV, HSV1, HSV2- DNA in cutaneous and mucocutaneous lesion samples from symptomatic patients. The assay is not intended for use with cerebral spinal fluid.